Drug Shortage Report for MINT-LOSARTAN/HCTZ DS

Last updated on 2023-01-03 History
Report ID 147790
Drug Identification Number 02389673
Brand name MINT-LOSARTAN/HCTZ DS
Common or Proper name losartan Hydrochlorothiazide
Company Name MINT PHARMACEUTICALS INC
Market Status DORMANT
Active Ingredient(s) HYDROCHLOROTHIAZIDE LOSARTAN POTASSIUM
Strength(s) 25.0MG 100.0MG
Dosage form(s) TABLET
Route of administration ORAL ORAL
Packaging size 100 count bottle
ATC code C09DA
ATC description ANGIOTENSIN II ANTAGONISTS, COMBINATIONS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2021-10-21
Estimated end date 2023-03-31
Actual end date
Shortage status Actual shortage
Updated date 2023-01-03
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 6575 DAVAND DRIVE
MISSISSAUGA, ONTARIO
CANADA L5T 2M3
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v6 2023-01-03 French Compare
v5 2023-01-03 English Compare
v4 2021-10-22 French Compare
v3 2021-10-22 English Compare
v2 2021-10-21 French Compare
v1 2021-10-21 English Compare

Showing 1 to 6 of 6